- Home
- TXMD vs NYC Comparison
TXMD vs NYC Comparison
Compare TXMD & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXMD | NYC |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 23.5M |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TXMD | NYC |
|---|---|---|
| Price | $2.02 | $8.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.3K | ★ 27.1K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 73.68 | ★ 85.28 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,761,000.00 | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $212.00 | ★ N/A |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.98 | $7.03 |
| 52 Week High | $2.95 | $16.30 |
Technical Indicators
Market Signals| Indicator | TXMD | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 47.49 |
| Support Level | $2.10 | $8.17 |
| Resistance Level | $2.29 | $9.37 |
| Average True Range (ATR) | 0.09 | 1.55 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 80.83 | 22.32 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.